Bionik Laboratories (BNKL) Income Statement
Bionik Laboratories Income Statement
Last quarter (Q4 2023), Bionik Laboratories's total revenue was $501.11K, an increase of 162.00% from the same quarter last year. In Q4, Bionik Laboratories's net income was $-1.42M. See Bionik Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 23 | Mar 22 | Mar 21 | Jun 20 | Mar 19 |
|---|---|---|---|---|---|
| $ 1.81M | $ 1.27M | $ 1.19M | $ 2.15M | $ 3.25M | |
| $ 989.88K | $ 953.26K | $ 923.80K | $ 1.26M | $ 1.62M | |
| $ 5.81M | $ 5.73M | $ 7.08M | $ 12.42M | $ 11.10M | |
| Depreciation and Amortization | $ 63.17K | $ 102.62K | $ 189.73K | $ 380.65K | $ 348.21K |
| $ -4.78M | $ -9.48M | $ -13.03M | $ -24.45M | $ -6.94M | |
| $ -4.83M | $ -4.77M | $ -6.16M | $ -11.25M | $ -7.29M | |
| $ -120.98K | $ -5.64M | $ -7.47M | $ -13.77M | $ -1.07M | |
| $ -4.95M | $ -10.41M | $ -13.62M | $ -25.02M | $ -10.56M | |
| $ -4.95M | $ -10.41M | $ -13.62M | $ -24.93M | $ -10.56M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.72 | $ -1.78 | $ -2.66 | $ -5.60 | $ -4.47 |
| Diluted EPS | $ -0.72 | $ -1.78 | $ -2.66 | $ -5.60 | $ -4.47 |
| Weighted Average Shares Outstanding | 6.90M | 5.84M | 5.13M | 4.46M | 2.36M |
| Weighted Average Shares Outstanding (Diluted) | 6.90M | 5.84M | 5.13M | 4.46M | 2.36M |
Currency in USD